Jci_page_head_homepage_01 Jci_page_head_homepage_02
Craig Brooks, Qingqing Wei, Sung-Gyu Cho, Zheng Dong
Published in Volume 119, Issue 5
J Clin Invest. 2009; 119(5):1275–1285 doi:10.1172/JCI37829
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
Suppression of mitochondrial fragmentation during RPTC injury by DN-Drp1.

RPTCs were cotransfected with MitoRed and DN-Drp1 or empty vector. Cells were then incubated with 10 mM azide for 3 hours or 20 μM cisplatin for 16 hours. (A) Effects of DN-Drp1 on mitochondrial fragmentation during azide-induced ATP depletion. (B) Effects of DN-Drp1 on mitochondrial fragmentation during cisplatin treatment. (C) Representative images of mitochondria. Left upper panel, untreated control cells showing long thread-like filamentous mitochondria; middle upper panel, fragmented mitochondria in vector-transfected cells after azide treatment; right upper panel, cells transfected with DN-Drp1 retaining filamentous mitochondria after azide treatment. Higher-magnification images of the framed areas are shown in the bottom panels. Scale bars: 5 μm (upper panels); 1 μm (lower panels). Data in A and B are presented as mean ± SD; n ≥ 3. *P < 0.05, significantly different from untreated control; #P < 0.05, significantly different from treated group transfected with empty vector.